Drug Discovery: From Target Validation to Lead Optimization | Talk by PD Dr. Aimo Kannt, Head of Research Division Drug Discovery, Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Frankfurt, on drug discovery
15. November 2022 | 4:00 pm | English | online
Probably more than in any other industry, sustainable growth and profitability of pharma companies rely on their ability to innovate and discover new treatments for diseases with unmet medical needs. This lecture will give an overview of the drug discovery process from target idea to preclinical development. It will focus on risk management in drug discovery and will outline scientific as well as organizational and strategic challenges associated with the different stages of pharma R&D.
Excursion to Sanofi, Frankfurt-Höchst
23. November 2022 | 9:00 – approx. 12:30
“Meet the expert” & bus tour across the site
Career Talk with Dr. Sarah Oelsner: Managing partner at Scitaris, a pharma and biotech R&D consulting
29. November 2022 | 4:00 pm | English | Online
More Information about Dr. Sarah Oelsner (Scitaris):
Sarah started her career with studying Pharmacy at the University of Heidelberg, and Molecular Genetics in Zaragoza, Spain. As she has always been curious to understand the biopharma industry from different perspectives, she worked for several years as a hospital and community pharmacist and later moved on to join the department of Immunology & Respiratory Diseases at the Novartis Institutes of Biomedical Research (NIBR), Basel. Driven by her passion for translational research, Sarah dedicated her PhD to Immuno-Oncology where she developed various novel chimeric antigen receptor (CAR)-modified lymphocytes in the group of Prof. Winfried Wels at the Georg-Speyer-Haus in Frankfurt.
She then moved into strategy consulting for several years, which made her notice the often limited science-driven decision-making in the biotech/pharma industry. This led Sarah and 2 other colleagues to found Scitaris in April 2019 – a boutique R&D life science strategy consultancy based in Berlin & Boston. The unifying conviction at Scitaris is that in the complex world of biopharma R&D, deep scientific and clinical understanding drive all viable business strategies and are crucial to successfully bring value to patients, drug developers and society.
Scitaris today has grown to a team of 22 international PhD scientists supporting biopharma companies in the US and Europe from answering focused strategic and technical questions around single assets to full-blown portfolio management and corporate strategy. Sarah will provide an overview of the range of projects Scitaris is working on and what expects you when moving from academia to a consulting career.
Scitaris currently offers several entry-level positions for recent PhD graduates and PostDoc with relevant Life Science background (biology, chemistry, biochemistry, pharmacy, medicine, bioinformatics etc.). Please submit your CV and cover letter to firstname.lastname@example.org until January 15th, 2023.
Open to those interested in all disciplines!
Karrieregespräch mit Dr. Martin M. Rudolph, Validierungsmanagement bei Biotest
8. Dezember 2022 | 16:30 Uhr | Deutsch | Online
Mehr Information zu Dr. Martin M. Rudolph: